Antimicrobial susceptibility of the uropathogens in out patients in Goiânia City, Goiás State;Suscetibilidade antimicrobiana de uropatógenos em pacientes ambulatoriais na Cidade de Goiânia, GO

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 38, Issue 5, 2005, Pages 416-420

  Poletto, Karine Queiroz ^a,b,c   Reis, Cleomenes ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b Fundação Universidade Regional de Gurupi   (Brazil)

^c Instituto Federal Catarinense   (Brazil)

Author keywords

Escherichia coli; Gram positive and gram negative bacteria; Urinary infection; Urine test

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; CEFTAZIDIME; COTRIMOXAZOLE; GENTAMICIN; LINEZOLID; NORFLOXACIN; VANCOMYCIN;

AGAR GEL DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; BRAZIL; CEDEACEA DAVISAE; CITROBACTER KOSERI; CYSTITIS; ENTEROBACTER AEROGENES; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; KLEBSIELLA; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NONHUMAN; OUTPATIENT; PROTEUS MIRABILIS; SALMONELLA; SERRATIA LIQUEFACIENS; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS SAPROPHYTICUS; STREPTOCOCCUS AGALACTIAE; URINALYSIS; URINARY TRACT INFECTION;

BACTERIA (MICROORGANISMS); CITROBACTER KOSERI; ENTEROBACTER AEROGENES; ENTEROCOCCUS; ESCHERICHIA COLI; KLEBSIELLA; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; POSIBACTERIA; PROTEUS MIRABILIS; SALMONELLA; SERRATIA LIQUEFACIENS; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS SAPROPHYTICUS; STREPTOCOCCUS AGALACTIAE;

EID: 25144504798     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822005000500011     Document Type: Article

References (42)

1. Abu-Shaqra Q. Occurrence and antibiotic sensitivity of Enterobacteriaceae isolated from a group of Jordanian patients with community acquired urinary tract infections. Cytobios 101:15-21, 2000.
2. Arias CA, Reyes J, Zúñiga M, Cortés L, Cruz C, Rico CL, Panesso D and on behalf of the Colombian Antimicrobial Resistance Group (RESCOL). Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002. Journal of Antimicrobial Chemotherapy 51: 59-68, 2003.
3. Astal Z, Manama A, Sharif FA. Antibiotic resistance of bacteria associated with community-acquired urinary tract infections in the southern area of the Gaza Strip. Journal Chemotherapy 14:259-264, 2002.
4. Azevedo PA, Cícero AGD, Gonçalves ALS, Rowe F, Teixeira LM. Evaluation of an automated system for the identification and antimicrobial susceptibility testing of enterococci. Diagnostic Microbiology and Infectious Disease 40:157-161, 2001.
5. Barros E, Bittencourt H, Caramori ML, Machado A. Antimicrobianos, consulta rápida. Artmed, Porto Alegre, 2001.
6. Bauer AW, Kirby EM. Antibiotic Susceptibility Testing by Standardized Single Disk Method. American Journal of Clinical Pathology 45:493-496, 1966.
7. Castro MS, Pilger D, Ferreira MBC, Kopittke L. Trends in antimicrobial utilization in a university hospital, 1990-1996. Revista de Saúde Pública 36:553-558, 2002.
8. 2. In: Curso de Estatística Aplicada à Biologia. UFG, Goiânia, p. 193-209, 1999.
9. Colodner R, Keness Y, Chazan B, Raz R. Antimicrobial susceptibility of community-acquired uropathogens in northern Israel. International Journal of Antimicrobial Agents 18:189-192, 2001.
10. Chaves JM, Moreira AA, Cunha FA, Carvalho MJP, Menezes EA. Perfil de resistência e sensibilidade dos antimicrobianos utilizados em infecções urinárias no Hospital de Referência São Lucas da cidade de Crateús-Ceará. Revista Brasileira de Análises Clínicas 35(supl): 38B, 2003.
11. Gordon KA, Jones RN. Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagnostic Microbiology and Infectious Disease 45:295-301, 2003.
12. Gram C. Uberdie Isolirte Farbung der Schizomycetem in Schmitt-und Trockenpaparaten. Fortschritte der Medizin 2:185-189, 1884.
13. Gupta K, Hooton TM, Roberts PL, Stamm WE. Patient-Initiated Treatment of Uncomplicated Recurrent Urinary Tract Infections in Young Women. Annals of Internal Medicine 135:9-16, 2001.
14. Jancel T, Dudas V. Management of uncomplicated urinary tract infections. Western Journal Medicine 176:51-55, 2002.
15. Jones RN, Ballow CH, Biedenbach and the ZAPS Study Group Medical Centers. Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: Report of the Ziyvox® Antimicrobial Potency Study (ZAPS) in the United States. Diagnostic Microbiology and Infectious Disease 40: 59-66, 2001.
16. Kahlmeter G. The EGO-SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and anti microbial susceptibility of urinary tract pathogens - interim report. Journal of Antimicrobial Chemotherapy 46 (supl I): 15-22, 2000.
17. KoethLM, King A, Knight H, May J, Miller LA, Phillips I, Poupard JA. Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method. Journal of Antimicrobial Chemotherapy 46: 369-376, 2000.
18. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WCJ. Diagnóstico Microbiológico. Medsi, Rio de Janeiro, 2001.
19. nd edition, Lea & Febiger, Philadelphia, 1974.
20. Lazarevic G, Petreska D, Pavlovic S. Antibiotic sensitivity of bacteria isolated from the urine of children with urinary tract infections from 1986 to 1995. Srpski Arhiv Za Celokupno Lekarstvo 126:423-429, 1998.
21. Luh KT, Hsueh PR, Teng LJ, Pan HJ, Chen YC, Lu JJ, Wu JJ, Ho SW. Quinupristin-Dalfopristin Resistance among Gram-Positive Bacteria in Taiwan Antimicrobic Agents and Chemotherapy 44: 3374-3380, 2000.
22. Martino MDV, Toporovski J, Ḿimica MI. Bacteriological methods for screening urinary tract infection during childhood and adolescence. Jornal Brasileiro de Nefrologia 24:71-80, 2002.
23. Menezes EA, Araújo GN, Lopes HM, Costa EP, Nascimento IRO, Cunha FA. Perfil de Susceptibilidade a Norfloxacina e ao Sulfazotrim no tratamento de Infecções Urinárias causadas por Escherichia coli no Laboratorio de Análises Clínicas de Esquadrão de Saúde da Base Aérea de Fortaleza. NewsLab ano IX 49:150-156, 2001.
24. Menezes EA, Melo OF, Oliveira IRN, Santos AS, Farias RB, Guerra ACP, Cunha FA. Bacteriúria assintomática em gestantes atendidas no Hospital da Base Aérea de Fortaleza. Laes & Haes 140:84-96, 2003.
25. Moges AF, Genetu A, Mengistu G. Antibiotic sensitivities of common bacterial pathogens in urinary tract infections at Gondar Hospital, Ethiopia. Eastern African of Medicine Journal 79: 140-142, 2002.
26. Moreira MAA, Costa FS, Nogueira NAP. Bacteriúria assintomática em gestantes atendidas no Centro de Saúde Ambulatorial Abdornal Machado (CESA-AM) em Crateús, CE. Revista Brasileira de Análises Clínicas 35(supl): 41B, 2003.
27. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Documents M7-A6 and M100-S13. Wayne, Pa, USA, 2003.
28. Navaneeth BV, Belwadi S, Suganthi N. Urinary pathogens resistance to common antibiotics: a retrospective analysis. Tropical Doctor 32:20-22, 2002.
29. Oliveira GA, Atobe JH, Mamizuka EM. Enterococcus spp: Importância clínica, fatores de virulência, resistência aos antimicrobianos e diagnóstico laboratorial. Laes&Haes 131:88-111, 2001.
30. Oliveira GA, Levy CE, Mamizuka EM. Staphylococcus aureus with intermediate resistance to vancomycin: mechanisms of resistance, laboratory detection and perspectives of appearance in Brazil. Jornal Brasileiro de Patologia 36:96-102, 2000.
31. Ortiz V, Maia RS. Como Diagnosticar e Tratar Infecções do trato urinário. Revista Brasileira de Medicina 56:149-155, 1999.
32. Palma PCR, Dambros M. Cistites na mulher. Revista Brasileira de Medicina 59:346-350, 2002.
33. Perry CM, Jarvis B. Linezolid: a review of its use in the management of serious Gram-positive infections. Drugs 61: 525-551, 2001
34. Ribeiro AS, Costa AM, Soto FS, Silva MQ, Silva RP. Estudo e prevalência de bactérias isoladas em urinoculturas de pacientes ambulatoriais. Revista Brasileira de Análises Clínicas 35(supl):33B, 2003.
35. Rieger A, Horta JA. Prevalência de patógenos bacterianos e perfil de sensibilidade aos antimicrobianos em uroculturas de amostras comunitárias Revista Brasileira de Análises Clínicas 35(supl): 37B, 2003.
36. Silva CHP. Elaboração e avaliação de um novo meio de cultura para a detecção e identificação presuntiva de enterobactérias produtoras de β-lactamase de espectro estendido (ESBL). Laes & Haes 127:148-160, 2000.
37. Sobel JD, Kaye D. Urinary tract infections. In: Mandel GL, Douglas RG, Bennett JE (eds) Principles and practice of infectious diseases. John Wiley&Sons, New York, p.582, 1990.
38. Stamm AMNF. Fatores de risco e incidência da infecção do trato urinário relacionada a cateterização vesical. Estudo observacional de coorte contemporânea, não controlado. Dissertação de mestrado, Universidade Federal de Santa Catarina, Florianópolis, SC, 1994.
39. th edition, Little Brown and Company, Boston, USA, p.895-912, 1996.
40. Steward CD, Stocker SA, Swenson JM, O'Hara CM, Edwards JR, Gaynes RP, McGowan Jr JE, Tenover FC. Comparison of Agar Dilution, Disk Diffusion, MicroScan, and Vitek Antimicrobial Susceptibility Testing Methods to Broth Microdilution for Detection of Fluoroquinolone-Resistant Isolates of the Family Enterobacteriaceae. Journal of Clinical Microbiology 37:544-547, 1999.
41. Tavares W. Manual de antibióticos e quimioterápicos. Artmed, São Paulo, 2001.
42. Weiss K, Rouleau D, Laverdiere M. Cystitis due to vancomycin-intermediare S. saprophyticus. Journal of Antimicrobial Chemotherapy 37:1039-1040, 1996.